Search - tctmd.com

Displaying 1 - 20 of 2071

Sort: Relevancy | Date

Hints of a Mortality Benefit With TTVR at 2 Years: TRISCEND II

News Conference News ACC 2026

Hints of a Mortality Benefit With TTVR at 2 Years: TRISCEND II

Yael L. Maxwell

April 07, 2026

Despite Guidelines, Aspirin Is Used in Fewer Than One in Four High-risk Pregnancies

News Conference News ACC 2026

Despite Guidelines, Aspirin Is Used in Fewer Than One in Four High-risk Pregnancies

Yael L. Maxwell

April 03, 2026

TCTMD’s Top 10 Most Popular Stories for March 2026

News Opinion Editor's Corner

TCTMD’s Top 10 Most Popular Stories for March 2026

April 01, 2026

HI-PEITHO: Catheter-Directed Therapy Bests Anticoagulation in Intermediate-Risk PE

News Conference News ACC 2026

HI-PEITHO: Catheter-Directed Therapy Bests Anticoagulation in Intermediate-Risk PE

March 28, 2026

CHAMPION-AF: A Win for Watchman FLX, but With Caveats

News Conference News ACC 2026

CHAMPION-AF: A Win for Watchman FLX, but With Caveats

March 28, 2026

Several Factors Linked to Subsequent Events After TIA, Minor Stroke

News Daily News

Several Factors Linked to Subsequent Events After TIA, Minor Stroke

March 23, 2026

TAVR-MET: Early Signs Point to Less Postprocedural Valve Dysfunction With Tirzepatide

News Conference News CRT 2026

TAVR-MET: Early Signs Point to Less Postprocedural Valve Dysfunction With Tirzepatide

March 19, 2026

LAAO Doesn’t Match Medical Therapy for High-risk AF Patients: CLOSURE-AF

News Conference News

Now Published: LAAO Doesn’t Match Medical Therapy for High-risk AF Patients in CLOSURE-AF

March 18, 2026

Echocardiographic Surveillance of AS Doesn’t Measure Up to Guidelines

News Daily News

Echocardiographic Surveillance of AS Doesn’t Measure Up to Guidelines

March 18, 2026

PARTNER 3: TAVI and SAVR Matched for Health Status at 7 Years

News Conference News CRT 2026

PARTNER 3: TAVI and SAVR Matched for Health Status at 7 Years

March 17, 2026

Apixaban Bests Rivaroxaban for Bleeding in VTE: COBRRA

News Daily News

Apixaban Bests Rivaroxaban for Bleeding in VTE: COBRRA

Yael L. Maxwell

March 16, 2026

CARPOOL Radial Access as Good as Femoral in PAD Procedures

News Conference News CRT 2026

CARPOOL Radial Access as Good as Femoral in PAD Procedures

March 16, 2026

Lower LDL Levels, Starting Earlier in Life: New ACC/AHA Dyslipidemia Guidelines

News Daily News

Lower LDL Levels, Starting Earlier in Life: New ACC/AHA Dyslipidemia Guidelines

Michael O'Riordan

March 13, 2026

Oral Anticoagulation Alone Best for Stable CAD Patients With AF: Meta-analysis

News Daily News

Oral Anticoagulation Alone Best for Stable CAD Patients With AF: Meta-analysis

Yael L. Maxwell

March 12, 2026

Large Variability in Use of Invasive Strategy for Type 1 NSTEMI: NCDR

News Conference News CRT 2026

Large Variability in Use of Invasive Strategy for Type 1 NSTEMI: NCDR

Michael O'Riordan

March 11, 2026

Experience Matters as Ross Procedure Gains Popularity in North America

News Daily News

Experience Matters as Ross Procedure Gains Popularity in North America

Michael O'Riordan

March 06, 2026

Optimal BP After HeartMate 3 LVAD May Be Higher Than Previously Thought

News Conference News THT 2026

Optimal BP After HeartMate 3 LVAD May Be Higher Than Previously Thought

March 04, 2026

CRT 2026: What to Expect in Washington, DC

News Conference News CRT 2026

CRT 2026: What to Expect in Washington, DC

March 04, 2026

NT-proBNP Provides Info on Who Will Fare Well After Tricuspid TEER

News Conference News THT 2026

NT-proBNP Provides Info on Who Will Fare Well After Tricuspid TEER

March 04, 2026

Healthy Lifestyle Plus GLP-1s Yields Bigger CV Reduction Than Drugs Alone

News Daily News

Healthy Lifestyle Plus GLP-1s Yields Bigger CV Reduction Than Drugs Alone

Michael O'Riordan

March 03, 2026

Country

First Name

Last Name

Email

Profession

Organization

Country

CAPTCHA

This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.